Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Beyond latent and active tuberculosis: a scoping review of conceptual frameworks.
Zaidi, SM A; Coussens, AK; Seddon, JA; Kredo, T; Warner, D; HOUBEN, RM G J; Esmail, H;
2023
eClinicalMedicine, (2023).66, 10.1016/j.eclinm.2023.102332.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa, B-T; Berry, C; Kazounis, E; Motta, I; Parpieva, N; Tigay, Z; Moodliar, R; DODD, M; Solodovnikova, V; Liverko, I; Rajaram, S; Rassool, M; McHugh, T; Spigelman, M; MOORE, DA; Ritmeijer, K; Du Cros, P; FIELDING, K; TB-PRACTECAL team,;
2023
The Lancet. Respiratory medicine, (2023).12 2 10.1016/S2213-2600(23)00389-2.
Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
Gray, AT; Macpherson, L; Carlin, F; Sossen, B; RICHARDS, AS; Kik, SV; HOUBEN, RM G J; MacPherson, P; Quartagno, M; Rogozińska, E; Esmail, H;
2023
PloS one, (2023).18 11 10.1371/journal.pone.0293535.
Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis.
HORTON, KC; RICHARDS, AS; EMERY, JC; Esmail, H; HOUBEN, RM G J;
2023
Proceedings of the National Academy of Sciences of the United States of America, (2023).120 47 10.1073/pnas.2221186120.
Shaping care home COVID-19 testing policy: a protocol for a pragmatic cluster randomised controlled trial of asymptomatic testing compared with standard care in care home staff (VIVALDI-CT).
Adams, N; Stirrup, O; Blackstone, J; Krutikov, M; Cassell, JA; Cadar, D; Henderson, C; Knapp, M; GOSCE, L; Leiser, R; Regan, M; Cullen-Stephenson, I; Fenner, R; Verma, A; Gordon, A; Hopkins, S; Copas, A; Freemantle, N; Flowers, P; Shallcross, L;
2023
BMJ open, (2023).13 11 10.1136/bmjopen-2023-076210.
The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis.
Millington, KA; WHITE, RG; Lipman, M; MCQUAID, CF; Hauser, J; Wooding, V; Potter, J; Abubakar, I; Wingfield, T;
2023
The Lancet. Respiratory Medicine, (2023).12 1 10.1016/S2213-2600(23)00409-5.
Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.
Barilar, I; Fernando, T; Utpatel, C; Abujate, C; Madeira, CM; José, B; Mutaquiha, C; KRANZER, K; Niemann, T; Ismael, N; De Araujo, L; Wirth, T; Niemann, S; Viegas, S;
2023
The Lancet. Infectious diseases, (2023).24 3 10.1016/s1473-3099(23)00498-x.
Recent Travel and Tuberculosis in Migrants: Data From a Low-Incidence Country.
SCHWALB, A; Kayumba, K; HOUBEN, RM G J; Bothamley, GH;
2023
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2023).78 3 10.1093/cid/ciad672.
Prevalence of subclinical pulmonary tuberculosis and its association with HIV in household contacts of index tuberculosis patients in two South African provinces: a secondary, cross-sectional analysis of a cluster-randomised trial.
Carter, N; WEBB, EL; Lebina, L; Motsomi, K; Bosch, Z; Martinson, NA; MacPherson, P;
2023
BMC Global and Public Health, (2023).1 1 10.1186/s44263-023-00022-5.
Assessing the efficacy of tuberculosis regimens in the presence of treatment non-adherence.
DODD, M; FIELDING, K; CARPENTER, J; THOMPSON, J; ELBOURNE, D;
2023
(2023).